Glibenclamide-induced blockade of ischemic preconditioning is time dependent in intact rat heart

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 272, Issue 6 41-6, 1997, Pages

  Schultz, Jo El J ^a   Yao, Zhenhai ^b   Cavero, Icilio ^c   Gross, Garrett J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Centre de Recherche de Vitry Alfortville   (France)

Author keywords

Adenosine 5' triphosphate sensitive potassium channels; Glibenclamide kinetics; Myocardial protection; Sulfonylurea receptor

Indexed keywords

GLIBENCLAMIDE; NICORANDIL; POTASSIUM CHANNEL; SULFONYLUREA DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HYPOTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 33751275016     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1997.272.6.h2607     Document Type: Article

References (16)

1. Armstrong, S. C., G. S. Liu, J. M. Downey, and C. E. Ganote. Potassium channels and preconditioning of isolated rabbit cardiomyocytes: effects of glyburide and pinacidil. J. Mol. Cell Cardiol. 27: 1765-1774, 1995.
2. Auchampach, J. A., I. Cavero, and G. J. Gross. Nicorandil attenuates myocardial dysfunction associated with transient ischemia by opening ATP-dependent potassium channels. J. Cardiovasc. Pharmacol. 20: 765-771, 1992.
3. ATP channels, and ischemic preconditioning in dogs. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H1327-H1336, 1993.
4. Auchampach, J. A., and G. J. Gross. Reduction in myocardial infarct size by the new potassium channel opener bimakalim. J. Cardiovasc. Pharmacol. 23: 554-561, 1994.
5. Auchampach, J. A., G. J. Grover, and G. J. Gross. Blockade of ischaemic preconditioning in dogs by the novel ATP-dependent potassium channel antagonist sodium 5-hydroxydecanoate. Cardiovasc. Res. 26: 1054-1062, 1992.
6. + channels in cardiac muscle. J. Pharmacol. Exp. Ther. 262: 71-79, 1991.
7. + channels in cardiac muscle by sulphonylurea drug glibenclamide. J. Pharmacol. Exp. Ther. 261: 540-545, 1992.
8. Findlay, I., E. Deroubaix, P. Guiraudou, and E. Corabouer. Effects of activation of ATP-sensitive potassium channels in mammalian ventricular myocyte. Am. J. Physiol. 257 (Heart Circ. Physiol. 26): H1551-H1559, 1989.
9. Fralix, T. A., C. Steenbergen, R. E. London, and E. Murphy. Glibenclamide does not abolish the protective effect of preconditioning on stunning in the isolated perfused rat heart. Cardiovasc. Res. 27: 630-637, 1993.
10. Galie, N., C. Guarnieri, G. P. Ussia, M. Zimarino, A. M. Traini, R. Parlangeli, I. Vaona, A. Branzi, and B. Magnani. Limitation of myocardial infarct size by nicorandil after sustained ischemia in pigs. J. Cardiovasc. Pharmacol. 26: 477-484, 1995.
11. 3H]glyburide, to neuronal and muscle preparations. J. Pharmacol. Exp. Ther. 257: 1162-1171, 1991.
12. Gross, G. J., and J. A. Auchampach. Blockade of the ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ. Res. 70: 223-233, 1992.
13. ATP Channel. Norwell, MA: Kluwer Academic, 1995, p. 99-120.
14. Grover, G. J., S. Dzwonczyk, C. S. Parham, and P. G. Sleph. The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogs. Cardiovasc. Drugs Ther. 4: 465-474, 1990.
15. Grover, G. J., S. Dzwonczyk, P. G. Sleph, and C. A. Sargent. The ATP-sensitive potassium channel blocker glibenclamide (glyburide) does not abolish preconditioning in isolated ischemic rat hearts. J. Pharmacol. Exp. Ther. 265: 559-564, 1993.
16. Grover, G. J., J. R. McCullough, D. E. Henry, M. L. Conder, and P. G. Sleph. Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of the effects with the potassium channel blocker glyburide. J. Pharmacol. Exp. Ther. 251: 98-104, 1989.